Blanket Purchase Agreement 47QTCA22D00CF-75F40126A00033
- The Food and Drug Administration established a Blanket Purchase Agreement with Calloway & Associates, Inc., Global Management Services Division, a certified service-disabled veteran-owned small business and woman-owned small business, on September 26, 2024, with a ceiling of $9.8 million and ultimate completion date of September 25, 2031. The BPA is established against the GSA Multiple Award Schedule and carries a Total Small Business set-aside. Performance occurs at locations including...
- The Food and Drug Administration (FDA), a civilian federal agency, has awarded a Blanket Purchase Agreement (BPA) to Calloway & Associates, Inc., a minority-owned, woman-owned, and service-disabled veteran-owned small business, for the provision of laboratory support technician services. The BPA has a ceiling value of $13,154,349.60 and a period of performance through September 26, 2025. Under this BPA, Calloway & Associates has received several task orders to provide laboratory...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to OCT Consulting LLC, an SBA-certified 8(a) small disadvantaged business. The contract has a ceiling value of $0.00 and an ultimate completion date of September 17, 2025. Under this BPA, OCT Consulting LLC has been awarded multiple task orders to provide professional search and recruitment services for leadership positions within the FDA's Center for Devices and...
- This Blanket Purchase Agreement (BPA) titled "OSP Professional Analytical Services" was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture. The $50,000,000 multiple-award BPA has a period of performance through February 14, 2028. The BPA is intended to procure professional analytical services in support of the FDA's Office of Strategic...
- The Food and Drug Administration established a Blanket Purchase Agreement with Booz Allen Hamilton Inc. on April 27, 2026, with a $200 million ceiling and ultimate completion date of April 26, 2027. This single-award BPA is established against the GSA Multiple Award Schedule and supports the Center for Biomedical Engineering and Regulatory Science (CBER) IT Systems Operations and Modernization (CSOM) program. The BPA covers IT systems operations and modernization services for FDA's Center for...
- The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc. as a single-award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, the BPA aims to procure scientific services in support of EO 14042 as described in the contract description. The BPA establishes an indefinite delivery/indefinite quantity...
- The Food and Drug Administration established a Blanket Purchase Agreement with Precise Software Solutions, Inc. on June 27, 2024, with a ceiling value of $99 million, to provide FDA/CFSAN information technology lifecycle development and management support services. Precise Software Solutions is an SBA-certified 8(a) Program participant. The BPA is issued against the GSA Multiple Award Schedule, a multiple-award vehicle providing access to IT services including web content management, software...
- This Blanket Purchase Agreement (BPA) entitled "OSP Professional Analytical Services" was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the prime contractor Guidehouse Inc., doing business as Navigant. The multiple-award BPA has a potential value of $50,000,000.00 and is set to expire on February 14, 2028. The BPA was established under the Office of Strategic Programs (OSP) Professional Analytical Services Indefinite...
- The Food and Drug Administration established a Blanket Purchase Agreement with International Consulting Associates, Inc. on August 13, 2024, with a ceiling of $98.8 million, set aside for total small business under the GSA Multiple Award Schedule. ICA is an SBA-certified 8(a) minority-owned small disadvantaged business. The BPA covers advancing regulatory science for clinical evidence generation, assessment, and analytics. Place of performance is Arlington, Virginia. The agreement extends...
- This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor A P Ventures, LLC, a woman-owned small disadvantaged business based in Columbia, Maryland. The contract has a ceiling value of $99,999,935.00 and a period of performance through February 2, 2030. The BPA is intended to provide the FDA with a wide range of regulatory review support services. A P Ventures, as the prime contractor, is an experienced...
- Multiple Award Schedule (MAS)Master GSA Schedule
- 47QTCA22D00CFFederal Supply Schedule
- 47QTCA22D00CF-75F40126A00033Blanket Purchase Agreement
The Food and Drug Administration established a Blanket Purchase Agreement with OLH Technical Services, LLC, an 8(a)-certified Alaskan Native Corporation, on September 26, 2026, with a ceiling of $9.8 million and performance extending through September 25, 2031. The BPA is established against the GSA Multiple Award Schedule. OLH Technical Services is SBA 8(a) certified through April 15, 2029. The BPA procures technical laboratory support services for the FDA. Place of performance is not specified in the source but aligns with FDA laboratory operations. Recent BPA activity reflects OLH's broader portfolio of federal forensic and laboratory operations work, including a $34.9 million competitive 8(a) labor-hours delivery order with the FBI Laboratory Division for daily laboratory operations and compliance support (awarded September 2024, extending through February 2030 in Anchorage and Quantico), and a $3.67 million competitive 8(a) delivery order with the FBI for six full-time DNA forensic examiners (awarded August 2025, through February 2030 in Anchorage). These orders demonstrate OLH's depth in federal laboratory and forensic services delivery, positioning the FDA BPA within a pattern of substantial investigative and laboratory support across federal law enforcement and civilian agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/15/26 |